NCT01013675 - Immunogenicity and Safety of a Cell-derived Influenza Vaccine in Elderly | Biotech Hunter

Enrollment

622

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Influenza Vaccines

Interventions

BIOLOGICAL

Influenza Vaccine

surface antigen, inactivated, prepared in cell cultures

BIOLOGICAL

Influenza Vaccine

surface antigen, inactivated, prepared in egg (influvac ®)

Trial Locations (12)

Site Reference ID/Investigator# 45009, Tallinn

Site Reference ID/Investigator# 45010, Tallinn

Site Reference ID/Investigator# 45017, Kaunas

Site Reference ID/Investigator# 45015, Kaunas

Site Reference ID/Investigator# 45016, Kaunas

Site Reference ID/Investigator# 45018, Kaunas

Site Reference ID/Investigator# 45013, Tartu

Site Reference ID/Investigator# 45007, Paide

Site Reference ID/Investigator# 45012, Saku

Site Reference ID/Investigator# 45019, Klaipėda

Site Reference ID/Investigator# 45005, Benátky nad Jizerou

Site Reference ID/Investigator# 45004, Hradec Králové